Skip to main content
AMICUS THERAPEUTICS, INC. logo

AMICUS THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · FOLD ISIN · US03152W1099 LEI · 549300MRD1SMUTNBPQ53 US Manufacturing
Filings indexed 1,650 across all filing types
Latest filing 2025-04-24 Annual Report
Country US United States of America
Listing US FOLD

About AMICUS THERAPEUTICS, INC.

https://www.amicusrx.com/

Amicus Therapeutics, Inc. is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering advanced therapies for people living with rare and devastating diseases. The company leverages innovative technology platforms to create high-quality medicines that address unmet medical needs in human genetic disorders. Its primary areas of focus include the research and commercialization of treatments for conditions such as Fabry disease and Pompe disease. Amicus Therapeutics is committed to being at the forefront of therapeutic development for rare metabolic diseases.

Recent filings

Filing Released Lang Actions
ARS
Annual Report
2025-04-24 English
DEFA14A
Regulatory Filings
2025-04-24 English
DEF 14A
Proxy Solicitation & Information Statement
2025-04-24 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-04-23 English
4
Director's Dealing
2025-03-18 English
4
Director's Dealing
2025-02-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.